Collections:
Other Resources:
DOI: 10.1182/blood.2021014689
Paper Summary:
Title: Asciminib: new therapeutic option in chronic phase CML with treatment failure.
Author(s): Yeung, David T; Shanmuganathan, Naranie; Hughes, Timothy P
Year: 2022
DOI: 10.1182/blood.2021014689
URL: https://doi.org/10.1182/blood.2021014689
Received on: 2022-10-26
✍: FYIcenter.com
2022-10-26, ∼1313👍, 0💬
Related Topics:
Popular Posts:
Paper Summary: Title: Angular Dependence of Si 3 N 4 Etching in C 4 F 6 /CH 2 F 2 /O 2 /Ar Plasmas A...
Paper Summary: DOI: 10.1016/j.evalprogplan.2 023.102317Received on: 2024-05-21
Paper Summary: DOI: 10.1109/ICOCO59262.2023. 10397847Received on: 2024-09-09
Paper Summary: Title: Usable Security and E-Banking: ease of use vis-a-vis security Author(s): Hertz...
Paper Summary: DOI: 10.1016/j.conbuildmat.20 21.125820Received on: 2024-04-04
